Serotonin Transporter Availability in Early Stage Parkinson's Disease and Multiple System Atrophy

Background. Differentiating Parkinson's disease (PD) from multiple system atrophy (MSA) can be challenging especially early in the course of the disease. Previous studies have shown that midbrain serotonin transporter (SERT) availability in patients with established MSA was significantly lower...

Descripción completa

Detalles Bibliográficos
Autores principales: Suwijn, S. R., Berendse, H. W., Verschuur, C. V. M., de Bie, R. M. A., Booij, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945177/
https://www.ncbi.nlm.nih.gov/pubmed/24693450
http://dx.doi.org/10.1155/2014/345132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945177/
https://www.ncbi.nlm.nih.gov/pubmed/24693450
http://dx.doi.org/10.1155/2014/345132

Ejemplares similares